진공 채혈관 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 튜브 소재별, 최종 용도별, 용도별, 지역별, 부문별 예측(2024-2030년)

Vacuum Blood Collection Tube Market Growth & Trends:

The global vacuum blood collection tube market size is projected to reach USD 3.64 billion by 2030, registering a CAGR of 3.23% during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic and infectious diseases, a growing number of blood transfusions, coupled with rising hematological disorders are boosting the adoption of blood collection tubes. In addition, frequent disease outbreaks in endemic areas are anticipated to increase the demand for blood collection tubes for clinical diagnostics. The market is anticipated to witness rapid growth owing to the factors, such as the growing need for the identification of infectious agents, cancer biomarkers, cardiovascular diseases, women's health issues, and substance abuse.

A blood test is performed for numerous indications, such as infection, anemia, hypokalemia, leukemia, and kidney function. Lab diagnostics, relying on diagnostic tests to commence the treatment of any disease condition, has played a substantial role in the demand growth of the tubes. In addition, contagious diseases have made the most important impact on any cause of hospital admissions. Currently, emerging and re-emerging infectious diseases are presenting public health danger. For instance, as per the WHO, almost 1.2 million people in the U.S. have HIV. Vacuum tubes are used routinely for the collection of blood specimens in laboratory diagnostics, globally. They have numerous advantages over the traditional method of drawing blood with the use of syringes as the closed vacuum tube assures phlebotomist safety and clean specimens due to minimal transferring and touching.

They are safer and easier to use and come with pre-added additives. The stopper's color coding is common, which makes it effortless to communicate and understand the medical community. Moreover, it also permits many tubes to be filled in one sitting; thereby lowering the chance of hemolysis. Vacutainers have other advantages as well, such as increased proficiency in diagnostic tests, shortened time of blood draws, and reduced needlestick injuries & risk of contamination. The COVID-19 pandemic has had a positive impact on industry growth owing to the increased government support for exploring the possibilities of allowing laboratories to enhance the blood testing process. However, since the beginning of the pandemic, the healthcare industry has been facing several challenges.

Currently, BD's specimen management business is challenged by a high demand for blood collection tubes, further challenging the company's capability to supply products and achieve necessary raw materials for its manufacturing plants. However, leading players expanded their manufacturing capabilities to fulfill the global demand for vacutainers during the pandemic. For instance, as of May 2022, BD announced that the supply of Vacutainer Citrate Tubes has been stabilized and is no longer on manual allocation or backorder. Furthermore, as per the data provided by the WHO, around 118.5 million units of donated blood are collected worldwide each year. From 2008 to 2018, an increase of 10.7 million blood donations from voluntary unpaid donors has been reported.

Thus, the rise in donations will increase the usage of the collection tubes; thereby accelerating the industry growth over the forecast period. However, the shortage of skilled personnel and lack of product awareness in low- and middle-income economies might hamper the industry growth. The growing aging population and experienced operators retiring without being replaced by lab technicians of the new generation are at the core, globally. Moreover, in 2022, a medical laboratory workforce study conducted by the University of Washington Center for Health Workforce Studies and ASCP found that challenges in the laboratory field comprise a shortage of qualified personnel, a falling number of accredited education programs, and increased demands due to vacancy rates and testing volumes.

Vacuum Blood Collection Tube Market Report Highlights:

• The serum-separating tube segment accounted for the largest share in 2023. These tubes have gained wide acceptance due to the benefit of the barrier gel that enables rapid separation of serum from cellular constituents of blood and thus lessens the hemolysis
• The PET/plastic material segment accounted for the largest share in 2023. Compared to glass, plastic decreases the exposure to biohazardous material following breakage, endures higher centrifugation speeds, has a greater shock resistance, weighs less, and is more effortlessly disposed of by incineration at a lower cost
• The blood routine examination application segment dominated the industry in 2023 owing to the factors, such as the prevalence of lifestyle diseases and the rise in awareness about routine examination
• The pathology laboratories end-use segment led the industry in 2023 due to the high prevalence of various diseases, such as hepatitis B, HIV AIDS, diabetes, cancer, and heart diseases, which require various blood tests to confirm the extremity of the disease
• North America was the largest region in 2023 due to the presence of leading clinical diagnostics companies & well-developed healthcare infrastructure and a high number of R&D activities

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Tube Material
  • 1.2.3. Application
  • 1.2.4. End-use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type and tube material outlook
  • 2.2.2. Application and end-use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Vacuum Blood Collection Tube Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing Prevalence Of Chronic And Infectious Diseases
    • 3.2.1.2. Growing Number Of Blood Transfusions
    • 3.2.1.3. Rising Hematological Disorders
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent Regulations For The Disposal Of The Tubes
• 3.3. Vacuum Blood Collection Tube Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Vacuum Blood Collection Tube Market: Type Estimates & Trend Analysis

• 4.1. Global Vacuum Blood Collection Tube Market: Type Dashboard
• 4.2. Global Vacuum Blood Collection Tube Market: Type Movement Analysis
• 4.3. Global Vacuum Blood Collection Tube Market by Type, Revenue
• 4.4. Serum Separating Tubes
  • 4.4.1. Serum separating tubes market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Plasma Separation Tubes
  • 4.5.1. Plasma separation tubes market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Therapeutic Drug Monitoring EDTA Tubes
  • 4.6.1. EDTA tubes market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Rapid Serum Tubes
  • 4.7.1. Rapid serum tubes market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Coagulation Tubes
  • 4.8.1. Coagulation tubes market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Other
  • 4.9.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Vacuum Blood Collection Tube Market: Tube Material Estimates & Trend Analysis

• 5.1. Global Vacuum Blood Collection Tube Market: Tube Material Dashboard
• 5.2. Global Vacuum Blood Collection Tube Market: Tube Material Movement Analysis
• 5.3. Global Vacuum Blood Collection Tube Market by Tube Material, Revenue
• 5.4. PET/Plastic
  • 5.4.1. PET/Plastic market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Glass
  • 5.5.1. Glass market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Vacuum Blood Collection Tube Market: Application Estimates & Trend Analysis

• 6.1. Global Vacuum Blood Collection Tube Market: Application Dashboard
• 6.2. Global Vacuum Blood Collection Tube Market: Application Movement Analysis
• 6.3. Global Vacuum Blood Collection Tube Market by Application Revenue
• 6.4. Serology & Immunology
  • 6.4.1. Serology & immunology market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Blood Routine Examination
  • 6.5.1. Blood routine examination market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Coagulation Tests
  • 6.6.1. Coagulation tests market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Genetic Studies
  • 6.7.1. Genetic studies market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Blood Sugar Assay
  • 6.8.1. Blood sugar assay market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Vacuum Blood Collection Tube Market: End-use Estimates & Trend Analysis

• 7.1. Global Vacuum Blood Collection Tube Market: End-use Dashboard
• 7.2. Global Vacuum Blood Collection Tube Market: End-use Movement Analysis
• 7.3. Global Vacuum Blood Collection Tube Market by End-use, Revenue
• 7.4. Hospitals & Clinics
  • 7.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Pathology Laboratories
  • 7.5.1. Pathology laboratories market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Blood Banks
  • 7.6.1. Blood banks market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Vacuum Blood Collection Tube Market: Regional Estimates & Trend Analysis by Type, Tube Material, Application, and End-use

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Mexico
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2023
  • 9.3.4. SEKISUI CHEMICAL CO., LTD.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. BD (Becton, Dickinson and Company)
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Cardinal Health
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Greiner AG
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Advin Health Care
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. AdvaCare Pharma
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Hindustan Syringes & Medical Devices Ltd
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. MB Plastic Industries
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Biota
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives